[ad_1]

obesity There is a serious disease that is growing rapidly not only in India but in the whole world. Be it children, elderly or youth, everyone is troubled by this disease. Obesity increases the risk of diabetes, heart disease and many other serious health problems. In such a situation, people use many supplements, fat loss pills, powder etc. to lose weight. Recently, on 24 June, Denmark’s pharma company Novo Nordisk launched its weight loss injection Vagovi in India. This injection is taken once a week and is a GLP1 receptor agonist, which can be beneficial for people who want to lose weight.
What is Vegavi?
Vegavi contains semaglutide, which belongs to the class of drugs called glucagon-like peptide-1 receptor agonist. It is designed to control type 2 diabetes. But due to its effective weight loss effects, it is also considered effective for the treatment of obesity.
How to injure Vegavi
Works? It works by mimicking the natural hormone GLP-1 in the body. It can be effective in controlling hunger and digestion. It works at centers that control hunger in the brain. It helps you reduce calories intake. Veg slowly slows down digestion, which makes the person feel full for a long time. It can help prevent more food.
What is the price of Vegovi?
Novo Nordisk has launched it in 5 doses. 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg. The monthly price of 0.25 Mg, 0.5 Mg and 1 MG dose has been kept at Rs 17,345. Which is Rs 4,366 per week. While the monthly price of 1.7 Mg and 2.4 Mg has been kept at Rs 24,280 and Rs 26,015. Which is Rs 6070 and Rs 6503 per week. This injection is taken once a week and comes in a device like Flextach Pen.
North India Statesman